In smaller patient populations, a significant enrichment of PEDF in high-density lipoprotein (HDL) particles has been found in patients with end stage renal disease compared to healthy controls, while the abundance of PEDF was lower in the HDL of transplanted patients, especially in patients with a good graft function. The gene discussed is SERPINF1; the disease is stage 5 chronic kidney disease.